Indications and Outcomes for Deferred Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Combination Therapy: Can Systemic Therapy be Withdrawn in Patients with No Evidence of Disease?

Background: Upfront cytoreductive nephrectomy (CN) is no longer the standard of care for patients with metastastic renal cell carcinoma (mRCC) with intermediate or poor prognosis according to the International mRCC Database Consortium categories. Objective: To investigate indications for CN followin...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Elisabeth E. Fransen van de Putte, Luna van den Brink, Mohamed A. Mansour, Johannes C. van der Mijn, Sofie Wilgenhof, Johannes V. van Thienen, John B.A.G. Haanen, Ekaterini Boleti, Thomas Powles, Patricia J. Zondervan, Niels M. Graafland, Axel Bex
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2023-09-01
Edice:	European Urology Open Science
Témata:	Cytoreductive Ipilimumab Nephrectomy Nivolumab Indications
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666168323003798
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!